healthŌme develops omics-based products that utilize genomic data to enhance cancer risk assessment and treatment navigation for individuals facing critical illnesses. Their Kadance program integrates precision health insights into life and critical illness insurance, improving patient support and optimizing treatment plans.
Funding
$10.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Individuals facing cancer often lack personalized risk assessment and navigation support, leading to suboptimal treatment plans and increased anxiety. Existing health systems are reactive and struggle to provide the necessary one-on-one guidance for managing complex illnesses like cancer. Molecular diagnostic tests that drive therapy selection and access to clinical trials are dramatically underutilized.
Solution
healthŌme's Kadance program integrates precision health insights into life and critical illness insurance, providing individuals with enhanced cancer resources to optimize treatment and recovery. By leveraging expert health navigation and genomic science, Kadance aims to improve the understanding of cancer risk, management, treatment response, and recovery. The program enhances health insurance by incorporating personalized insights derived from an individual's DNA, answering critical questions related to inherited cancer risk and medication effectiveness. Kadance provides invaluable cancer resources to optimize cancer treatment plans and recovery.
Target Audience
The primary target audience includes individuals seeking personalized cancer risk assessment and treatment navigation, as well as insurance carriers and agents looking to enhance their offerings with precision health insights.
Features
- Genomic-based cancer risk assessment to understand inherited predispositions.
- Molecular diagnostic test utilization to drive therapy selection and access to clinical trials.
- Expert health navigation to guide individuals through the complexities of cancer treatment.
- Personalized insights derived from DNA analysis to optimize medication choices.
- Integration with existing critical illness or life insurance policies to increase policyholder value.